Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Molecular Biology Reports|December 14, 2022
Werner helicase is required for proliferation and DNA damage repair in multiple myelomaDilara Akcora-Yildiz, Tulin Ozkan, Mehmet Ozen, et al.
Bioorganic Chemistry|May 10, 2024
Synthesis of novel indol-3-acetamido analogues as potent anticancer agents, biological evaluation and molecular modeling studiesFatima Doganc, Tulin Ozkan, Nazila Farhangzad, et al.
International Journal of Molecular Sciences|July 19, 2016
Methylsulfonylmethane Induces p53 Independent Apoptosis in HCT-116 Colon Cancer CellsArzu Zeynep Karabay, Asli Koc, Tulin Ozkan, et al.
Toxicology in Vitro : an International Journal Published in Association with BIBRA|December 7, 2023
Nilotinib exhibits less toxicity than imatinib and influences the immune state by modulating iNOS, p-p38 and p-JNK in LPS/IFN gamma-activated macrophagesArzu Zeynep Karabay, Tulin Ozkan, Asli Koc, et al.
Journal of Clinical Medicine|February 11, 2023
Co-Culture of Cryopreserved Healthy Sertoli Cells with Testicular Tissue of Non-Obstructive Azoospermia (NOA) Patients in Culture Media Containing Follicle-Stimulating Hormone (FSH)/Testosterone Has No Advantage in Germ Cell MaturationO Sena Aydos, Yunus Yukselten, Tulin Ozkan, et al.
Cellular and Molecular Biology (Noisy-Le-Grand, France)|May 30, 2018
Characterization of imatinib-resistant K562 cell line displaying resistance mechanismsYalda Hekmatshoar, Tulin Ozkan, Buket Altinok Gunes, et al.
Molecular Biology Reports|January 30, 2021
Cytotoxic effect of 6-Shogaol in Imatinib sensitive and resistant K562 cellsTulin Ozkan, Yalda Hekmatshoar, Hanife Pamuk, et al.
Leukemia Research|February 19, 2021
Assessment of azithromycin as an anticancer agent for treatment of imatinib sensitive and resistant CML cellsTulin Ozkan, Yalda Hekmatshoar, Arzu Zeynep Karabay, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|June 25, 2024
Identification of exosomal microRNAs and related hub genes associated with imatinib resistance in chronic myeloid leukemiaArzu Zeynep Karabay, Tulin Ozkan, Aynur Karadag Gurel, et al.
Anti-Cancer Agents in Medicinal Chemistry|January 5, 2018
Determination of the Apoptotic Effect and Molecular Docking of Benzamide Derivative XT5 in K562 CellsTulin Ozkan, Yalda Hekmatshoar, Tugba Ertan-Bolelli, et al.
Pageof 3